WT-1 expression in gastrointestinal stromal tumours

Pathology

Volumn 42, Issue 1, 2010, Pages 54-57

  Kang, Gu Hyun ^a   Kim, Kyoung Mee ^a   Noh, Jae Hyung ^a   Sohn, Tae Sung ^a   Kim, Sung ^a   Park, Cheol Keun ^a   Lee, Choong Sik ^b   Kang, Dae Young ^b  

^a Sungkyunkwan University   (South Korea)

^b Chungnam National University   (South Korea)

Author keywords

Gastrointestinal stromal tumour; Immunohistochemistry; WT 1

Indexed keywords

EID: 73649134692     PISSN: 00313025     EISSN: 14653931     Source Type: Journal    
DOI: 10.3109/00313020903434413     Document Type: Article

References (29)

1. Scharnhorst V, van der Eb AJ, Jochemsen AG. WT1 proteins: functions in growth and differentiation. Gene 2001; 273: 141-161
2. Gessler M, Poustka A, Cavenee W, et al. Homozygous deletion in Wilms tumours of a zinc-finger gene identified by chromosome jumping. Nature 1990; 343: 774-778
3. Call KM, Glaser T, Ito CY, et al. Isolation and characterization of a zinc finger polypeptide gene at the human chromosome 11 Wilms' tumor locus. Cell 1990; 60: 509-520
4. Oji Y, Yamamoto H, Nomura M, et al. Overexpression of the Wilms' tumor gene WT1 in colorectal adenocarcinoma. Cancer Sci 2003; 94: 712-717 (Pubitemid 37160929)
5. Oji Y, Miyoshi S, Maeda H, et al. Overexpression of the Wilms' tumor gene WT1 in de novo lung cancers. Int J Cancer 2002; 100: 297-303.
6. Sotobori T, Ueda T, Oji Y, et al. Prognostic significance of Wilms tumor gene (WT1) mRNA expression in soft tissue sarcoma. Cancer 2006; 106: 2233-2240
7. Oji Y, Suzuki T, Nakano Y, et al. Overexpression of the Wilms' tumor gene WT1 in primary astrocytic tumors. Cancer Sci 2004; 95: 822-827 (Pubitemid 39545589)
8. Nakatsuka S, Oji Y, Horiuchi T, et al. Immunohistochemical detection of WT1 protein in a variety of cancer cells. Mod Pathol 2006; 19: 804-814
9. Drakos E, Rassidakis GZ, Tsioli P, et al. Differential expression of WT1 gene product in non-Hodgkin lymphomas. Appl Immunohistochem Mol Morphol 2005; 13: 132-137
10. Muir TE, Cheville JC, Lager DJ. Metanephric adenoma, nephrogenic rests, and Wilms' tumor: A histologic and immunophenotypic comparison. Am J Surg Pathol 2001; 25: 1290-1296
11. Ordonez NG. Desmoplastic small round cell tumor: II: An ultrastructural and immunohistochemical study with emphasis on new immunohistochemical markers. Am J Surg Pathol 1998; 22: 1314-1327
12. Ordonez NG. Value of thyroid transcription factor-1, E-cadherin, BG8, WT1, and CD44S immunostaining in distinguishing epithelial pleural mesothelioma from pulmonary and nonpulmonary adenocarcinoma. Am J Surg Pathol 2000; 24: 598-606.
13. Acs G, Pasha T, Zhang PJ. WT1 is differentially expressed in serous, endometrioid, clear cell, and mucinous carcinomas of the peritoneum, fallopian tube, ovary, and endometrium. Int J Gynecol Pathol 2004; 23: 110-118
14. Bergmann L, Miething C, Maurer U, et al. High levels of Wilms' tumor gene (wt1) mRNA in acute myeloid leukemias are associated with a worse long-term outcome. Blood 1997; 90: 1217-1225
15. Miyoshi Y, Ando A, Egawa C, et al. High expression of Wilms' tumor suppressor gene predicts poor prognosis in breast cancer patients. Clin Cancer Res 2002; 8: 1167-1171 (Pubitemid 34517654)
16. Oka Y, Tsuboi A, Taguchi T, et al. Induction of WT1 (Wilms' tumor gene)-specific cytotoxic T lymphocytes by WT1 peptide vaccine and the resultant cancer regression. Proc Natl Acad Sci USA 2004; 101: 13885-13890
17. Bing Z, Pasha TL, Acs G, et al. Cytoplasmic overexpression of WT-1 in gastrointestinal stromal tumor and other soft tissue tumors. Appl Immunohistochem Mol Morphol 2008; 16: 316-321
18. Hornick JL, Fletcher CD. The role of KIT in the management of patients with gastrointestinal stromal tumors. Hum Pathol 2007; 38: 679-687
19. Hohenstein P, Hastie ND. The many facets of the Wilms' tumour gene, WT1. Hum Mol Genet 2006; 15(Spec No 2): R196-201.
20. Haber DA, Englert C, Maheswaran S. Functional properties of WT1. Med Pediatr Oncol 1996; 27: 453-455
21. Niksic M, Slight J, Sanford JR, et al. The Wilms' tumour protein (WT1) shuttles between nucleus and cytoplasm and is present in functional polysomes. Hum Mol Genet 2004; 13: 463-471
22. Harada Y, Nonomura N, Nishimura K, et al. WT1 gene expression in human testicular germ-cell tumors. Mol Urol 1999; 3: 357-364
23. Oji Y, Inohara H, Nakazawa M, et al. Overexpression of the Wilms' tumor gene WT1 in head and neck squamous cell carcinoma. Cancer Sci 2003; 94: 523-529
24. Rossi G, Valli R, Bertolini F, et al. PDGFR expression in differential diagnosis between KIT-negative gastrointestinal stromal tumours and other primary soft-tissue tumours of the gastrointestinal tract. Histopathology 2005; 46: 522-531
25. George D. Platelet-derived growth factor receptors: A therapeutic target in solid tumors. Semin Oncol 2001; 28: 27-33.
26. Heldin CH, Eriksson U, Ostman A. New members of the plateletderived growth factor family of mitogens. Arch Biochem Biophys 2002; 398: 284-290
27. Wang ZY, Madden SL, Deuel TF, et al. The Wilms' tumor gene product, WT1, represses transcription of the platelet-derived growth factor A-chain gene. J Biol Chem 1992; 267: 21999-22002
28. Oka Y, Elisseeva OA, Tsuboi A, et al. Human cytotoxic T-lymphocyte responses specific for peptides of the wild-type Wilms' tumor gene (WT1 ) product. Immunogenetics 2000; 51: 99-107. (Pubitemid 30150969)
29. Tsuboi A, Oka Y, Osaki T, et al. WT1 peptide-based immunotherapy for patients with lung cancer: report of two cases. Microbiol Immunol 2004; 48: 175-184